This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08426/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08426/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB08426/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08426/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08426/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08426
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08426 n14:DB08426
dcterms:title
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE
adms:identifier
n9:DB08426 n10:PR2 n11:393112 n12:445481 n13:99444897
n3:IUPAC-Name
n4:271B56EB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B56F1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B56F0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B56ED-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B56EE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B56EF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B56E9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B56EA-363D-11E5-9242-09173F13E4C5 n4:271B56E7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B56E8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B56F7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B56F8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B56F2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B56F3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B56F5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B56F4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B56F6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B56FD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B56FF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5700-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B56FC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B56FB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B56FE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B56EC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B56F9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B56FA-363D-11E5-9242-09173F13E4C5